Hans Biomed

Hans Biomed EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hans Biomed (042520.KQ) as of Nov 1, 2026 is 2.99 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -2.27 B KRW — a change of -231.84% (higher).

EBITDA

2.99 BKRW

YoY

-231.84%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hans Biomed is 2024 2.99 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hans Biomed was 2023 -2.27 B KRW. It decreases by -231.84% higher compared to the previous year.

The Hans Biomed EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
9.60 B KRW
Jan 1, 2018
6.66 B KRW
Jan 1, 2019
11.52 B KRW
Jan 1, 2020
-1.62 B KRW
Jan 1, 2021
-13.97 B KRW
Jan 1, 2022
3.22 B KRW
Jan 1, 2023
-2.27 B KRW
Jan 1, 2024
2.99 B KRW
The Hans Biomed EBITDA history
YEAREBITDAYoY
2.99 BKRW-231.84%
-2.27 BKRW-170.32%
3.22 BKRW-123.09%
-13.97 BKRW+759.56%
-1.62 BKRW-114.11%
11.52 BKRW+72.96%
6.66 BKRW-30.64%
9.60 BKRW+60.80%
5.97 BKRW+16.85%
5.11 BKRW+29.18%
3.95 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hans Biomed Stock analysis

What does Hans Biomed do? Hans Biomed Corp manufactures and sells graft material and silicon products under brand names SureDerm, BellaGen, and GPS for skin-implant materials used in burn treatment and skin graft. The company offers bone-implant materials including allogeneic bones, xenogenous bones, and synthetic bones under SureFuse, ExFuse, and SureOss for dentistry and orthopedic applications. Silicone products such as BellaGel and Scar Clinic are utilized for scar treatment and breast implants. The firm also provides hair transplanters as part of its product portfolio. Skin-implant materials under SureDerm, BellaGen, and GPS are purchased by medical facilities for burn treatment and skin graft procedures. Bone-implant materials under SureFuse, ExFuse, and SureOss are bought by dental and orthopedic clinics for various surgical needs. Silicone products BellaGel and Scar Clinic are acquired by healthcare providers for scar management and breast implant surgeries. Hair transplanters are sold to medical institutions requiring such equipment. The company's primary revenue streams come from the sale of skin-implant materials, bone-implant materials, and silicone products across medical, dental, and orthopedic sectors. Medical facilities, dental clinics, and orthopedic practices represent key customer segments. Brand names SureDerm, BellaGen, GPS, SureFuse, ExFuse, SureOss, BellaGel, and Scar Clinic drive product differentiation and market positioning in the healthcare industry. Hans Biomed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hans Biomed stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hans Biomed is 2.99 B KRW in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hans Biomed changed from -2.27 B KRW to 2.99 B KRW, representing a -231.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Hans Biomed since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Hans Biomed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hans Biomed

All Key Metrics — Hans Biomed